Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home
  • Log in
  • My Cart

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
Inaugural Article

Imaging the glycome

Scott T. Laughlin and Carolyn R. Bertozzi
  1. Departments of aChemistry and
  2. bMolecular and Cell Biology, and
  3. cHoward Hughes Medical Institute, University of California, Berkeley, CA 94720; and
  4. dThe Molecular Foundry, Materials Science Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720

See allHide authors and affiliations

PNAS January 6, 2009 106 (1) 12-17; https://doi.org/10.1073/pnas.0811481106
Scott T. Laughlin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn R. Bertozzi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: crb@berkeley.edu
  1. Contributed by Carolyn R. Bertozzi, November 11, 2008 (received for review June 23, 2008)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Abstract

Molecular imaging enables visualization of specific molecules in vivo and without substantial perturbation to the target molecule's environment. Glycans are appealing targets for molecular imaging but are inaccessible with conventional approaches. Classic methods for monitoring glycans rely on molecular recognition with probe-bearing lectins or antibodies, but these techniques are not well suited to in vivo imaging. In an emerging strategy, glycans are imaged by metabolic labeling with chemical reporters and subsequent ligation to fluorescent probes. This technique has enabled visualization of glycans in living cells and in live organisms such as zebrafish. Molecular imaging with chemical reporters offers a new avenue for probing changes in the glycome that accompany development and disease.

  • azide
  • chemical reporter
  • click chemistry
  • glycan
  • bioorthogonal

Molecular imaging reveals a wealth of information about biomolecules in their native environments (1). Subcellular localization of proteins (2) and RNAs (3), protein-expression patterns (4), protein–protein interactions (5), and ion concentrations (6) can be assayed with minimal perturbation to the organism or process under study. Despite the power of molecular imaging, the varieties of biomolecules amenable to such detailed scrutiny are few. Proteins are perhaps most accessible to in vivo visualization, because they are easily manipulated with genetics to generate autofluorescent protein chimeras (7). Certain small molecules and ions, including calcium (8), copper (9), lead (10), zinc (11), mercury (12), cAMP (13), and hydrogen peroxide (14), may also be imaged by using cleverly designed small-molecule fluorophores or reengineered fluorescent proteins. However, extension of molecular imaging to other biomolecule classes (i.e., glycans and lipids) has proved challenging (15).

Glycans are particularly attractive targets for in vivo imaging. These biopolymers play key roles in numerous biological processes (16, 17). For example, cell-surface glycans participate in cell–cell interactions involved in embryonic development (18), leukocyte homing (19), and cancer cell metastasis (20, 21). The wide range of functions that glycans can fulfill reflects their structural variety (Fig. 1) (22). Vertebrate glycans are components of glycoproteins, glycolipids, and proteoglycans, and may be membrane-associated, intracellular, or secreted. Built from monosaccharide building blocks that are connected in both linear and branched geometries, the glycans possess structural diversity that can far exceed that of the linear biopolymers. Further, the totality of glycans that a cell produces, collectively termed the cell's “glycome,” is influenced by the cell's genome, transcriptome, and proteome, as well as environmental cues and nutrients (23). Thus, the glycome reports on the physiological state of the cell and, not surprisingly, changes in the glycome have been associated with disease. The ability to witness such changes in the context of living organisms would augment our understanding of systems biology and provide new clinical tools for disease diagnosis.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Examples of glycoconjugate structures found in vertebrates. The glycans can be long and linear, as in the glycosaminoglycan chondroitin sulfate, or as simple as a single monosaccharide, as in cytosolic and nuclear O-GlcNAc-modified proteins. Branched structures are typical for the N-glycans and O-glycans found on glycoproteins and in glycolipids.

Glycans are not directly encoded in the genome and are thus not amenable to imaging techniques that rely on genetic reporters (24). Rather, efforts to image glycans in vivo have focused on the use of affinity reagents and chemical tools (15, 24). Herein, we review the various strategies available to image glycans, with a focus on our own work: using the bioorthogonal chemical reporter strategy to visualize glycans both ex vivo and in living organisms.

Imaging Glycans with Lectins and Antibodies

Lectins are naturally occurring glycan-binding proteins (25) that have been widely used for the detection (26) and enrichment (27) of glycoconjugates. Lectins are able to recognize structures as varied as the monosaccharides sialic acid (28) and fucose (29), and higher-order structures such as the Tn (30) and sialyl-Tn tumor antigens (31) and the conserved core region of N-glycans (32). However, lectins typically have low affinity for their glycan epitope and require multivalency for high-avidity binding (33). Moreover, lectins are generally tissue-impermeable and often toxic (34, 35). For these reasons the utility of lectins for imaging in living systems is limited, although they have been widely used to visualize glycans ex vivo. The use of lectins to probe specific glycans on cultured cell lines is well precedented (36, 37). Lectins have enabled glycan visualization on tissue sections or whole-mount specimens at discrete time points in mouse (38), chick (39), and fly (40) embryogenesis, as well as in the mature mouse thymus (41), rat endothelial vasculature (42), and human kidney (43). Further, lectins have been used to facilitate screening of Caenorhabditis elegans mutants with glycosylation defects (44, 45).

Like lectins, antibodies generated against glycan structures enable the visualization of these molecules ex vivo but have limited use in vivo. Antibodies are able to recognize very specific glycan structures. Indeed, there are well-characterized commercially available monoclonal antibodies that bind distinct epitopes on heparan (46) and chondroitin sulfate (47), as well as sialyl Lewis x (48), sulfoadhesin (49), and O-linked N-acetylglucosamine (O-GlcNAc) (50), among many others. Theoretically, an antibody may be generated against any glycan epitope; however, the synthesis of even small glycan structures can be unwieldy (51), complicating the generation of a hapten for immunization. Like lectins, antibodies are also tissue-impermeant, and most antibodies generated against glycan epitopes are of the low-affinity IgM subtype. Nevertheless, applications to immunofluorescence microscopy of cultured cells or tissue sections abound. Antibodies have been used for glycan visualization on fixed cells (52), as well as sections from chick cornea (53), bovine mammary gland (54), rabbit appendix (55), and human thymus (56), among others.

Only in 1 report has a glycan-specific antibody been used for in vivo imaging. Licha et al. (57) succeeded in visualizing the peripheral lymph node endothelial glycan termed sulfoadhesin in mice by using the MECA-79 antibody. This sulfated glycan, which serves as a ligand for the leukocyte adhesion molecule L-selectin, is also a marker of pathological inflammation that occurs during diabetes, asthma, and arthritis (58). Although in the published work only lymph nodes were imaged, a similar approach may permit clinical imaging of chronic inflammatory diseases.

Lectin and antibody-based imaging methods provide a snapshot of the glycome at a particular point in time, but are difficult to implement in the context of dynamic studies. Further, with limited in vivo applicability, these reagents require removal of the cells or tissues of interest from their native environment before analysis. Thus, we have focused on developing complementary methods for glycan imaging that permit in vivo analysis of dynamic changes in the glycome.

Imaging Glycans with Bioorthogonal Chemical Reporters

We developed a 2-step approach to glycan imaging that employs only small-molecule reagents (Fig. 2A) (15). First, a chemically reactive moiety is incorporated into target glycans by metabolic labeling with an unnatural monosaccharide substrate. The chemically reactive group is termed a “chemical reporter.” In the second step, the reporter group is visualized by covalent reaction with an imaging probe. The requirements on the chemical nature of the reporter are demanding. The reporter must be small enough to be ignored by the cell's metabolic enzymes, and inert to the endogenous chemical functionality of the cell. This latter criterion is also referred to as the property of “bioorthogonality.”

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

The bioorthogonal chemical reporter strategy for imaging glycans. (A) Glycans can be metabolically labeled with unnatural sugars bearing a chemical reporter group. The chemical reporter group, typically an azide or terminal alkyne, can be detected in a second step by covalent reaction with a probe. (B) Bioorthogonal reactions used to visualize chemical reporters appended to unnatural sugars (R). Azides can be detected by Staudinger ligation with triaryl phosphines, resulting in the formation of an amide linkage between the reporter and the probe. Azides and terminal alkynes can be detected by reaction with each other via CuAAC, forming in a triazole linkage between the reporter and probe. The azide can also be detected by Cu-free click chemistry with strained cyclooctynes. This latter reaction avoids the use of a cytotoxic metal catalyst.

The first chemical reporter used to visualize glycans was the ketone group, which can be detected by oxime or hydrazone formation with aminooxy- or hydrazide-functionalized probes, respectively (59). However, these covalent reactions perform best at reduced pH (5.5–6.5) and are sluggish at pH 7.4, thus limiting their utility in vivo. Greater progress in glycan imaging has been made by using azides and alkynes as bioorthogonal chemical reporters. Both of these functional groups are small, biologically inert, and capable of reacting with other bioorthogonal functional groups at physiological pH. The azide can be detected by reaction with phosphines via the Staudinger ligation (60), linear alkynes via the Cu-catalyzed azide-alkyne cycloaddition (abbreviated CuAAC) (61, 62), and with a variety of cyclooctynes via the strain-promoted azide-alkyne cycloaddition (also termed “Cu-free click chemistry”) (Fig. 2B) (63–65). The alkyne can be detected with exogenously delivered azides via the CuAAC reaction (Fig. 2B). The azide and alkyne reactions described above are not equally compatible with living systems. The Cu catalyst required in the CuAAC reaction is cytotoxic, thus limiting this reaction to use with fixed cells or tissues.

Metabolic Labeling of Glycan Subtypes with Chemical Reporters.

Most glycan subtypes, with the notable exception of glycosaminoglycans and glycosylphosphatidylinositol anchors, have been imaged by metabolic labeling with azido or alkynyl monosaccharides (Fig. 3). The first of these were glycoconjugates bearing the terminal monosaccharide N-acetylneuraminic acid (Neu5Ac), a member of the sialic acid family. This sugar holds a privileged status in the field of glycobiology, having been identified as a determinant of viral infection, leukocyte-endothelial cell adhesion, neuronal development, immune cell activation, cancer metastasis, and many other normal and pathological processes (66, 67).

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Azide- and alkyne-bearing monosaccharides used for metabolic labeling of glycans. Sialic acids may be labeled with N-azidoacetylneuraminic acid (SiaNAz), ManNAz, 9-azido N-acetylneuraminic acid, and alkynyl ManNAc. GalNAc-containing glycans and O-GlcNAc-labeled glycans may be labeled with azides by using GalNAz. O-GlcNAc-labeled glycans may also be labeled with GlcNAz. Fucose-containing glycans may be labeled with 6AzFuc or alkynyl fucose. Structures are shown in peracetylated form, which are typically used for metabolic labeling experiments. After cell entry by passive diffusion, the acetyl groups are cleaved by cytosolic esterases.

Sialic acid-containing glycans can be visualized by metabolic labeling with analogs of its biosynthetic precursor N-acetylmannosamine (ManNAc) or with derivatives of sialic acid (Fig. 3). The biosynthetic machinery will tolerate the addition of chemical reporters to the N-acyl group of either substrate class [e.g., Ac4ManNAz (60), alkynyl ManNAc (68), and SiaNAz (69)] or at C-9 of the sialic acid (e.g., 9-azido Neu5Ac) (70). Indeed, when mammalian cell lines are incubated with Ac4ManNAz, SiaNAz replaces 4–41% of natural sialic acids (71). Ac4ManNAz has been used to visualize sialic acids in a diverse range of cell types (71), as well as living mice (72) and zebrafish (73). Alkynyl ManNAc has been used to visualize sialic acids on human cancer cell lines and for glycoproteomic analysis of labeled glycoproteins (68, 74).

Mucin-type O-linked glycans have also been studied with the chemical reporter strategy. These structures share a common core N-acetylgalactosamine (GalNAc) residue that links the glycan to serine or threonine residues within the underlying protein (Fig. 1). Metabolic labeling of the core GalNAc residue can be achieved by treating cells or animals with per-O-acetylated N-azidoacetylgalactosamine (Ac4GalNAz) (75). This unnatural sugar is processed by the GalNAc salvage pathway to form the intermediate uridine diphospho (UDP)-GalNAz, which is recognized by a family of polypeptide GalNAc transferases in the Golgi compartment. Ac4GalNAz has been used to label mucin-type O-linked glycans in numerous cell lines, live mice (76), and zebrafish (73).

O-GlcNAc-modified proteins (77), which occur in the cytosol and nucleus, have been labeled with bioorthogonal chemical reporters by using either N-acetylglucosamine (GlcNAc) or GalNAc analogs. Per-O-acetylated N-azidoacetylglucosamine (Ac4GlcNAz) (78) is modified by the GlcNAc salvage pathway enzymes to form UDP-GlcNAz, which is used as a substrate by the cytosolic O-GlcNAc transferase. Alternatively, Ac4GalNAz is metabolized to form UDP-GalNAz, which can be converted to UDP-GlcNAz in situ by an epimerase (79). Ac4GlcNAz has been used for the identification of O-GlcNAc-modified proteins in cell lysates (78) and Ac4GalNAz has been used to image nuclear O-GlcNAc-modified proteins in cultured cells (M. J. Hangauer and C.R.B., unpublished work).

Fucosylated glycans, like those bearing sialic acid, have been implicated in myriad normal and pathological processes (80). As such, they have been attractive and heavily pursued targets for imaging with chemical reporters (68, 81, 82). Fucosylated glycans have been metabolically labeled by using per-O-acetylated 6-azidofucose (6AzFuc) or per-O-acetylated 6-alkynylfucose (alkynyl fucose), both of which exploit the fucose salvage pathway. So far, these fucose reporters have been limited to use in cultured cells because of low levels of metabolic incorporation and cytotoxicity.

Imaging of Glycans on Cultured Cells with the Chemical Reporter Strategy.

Imaging of azide- and alkyne-labeled glycans on cultured cells has been accomplished with fluorophore-conjugated phosphines and alkynes. Chang et al. (83) were able to visualize cell-surface SiaNAz residues on live cells by Staudinger ligation with fluorescein-, rhodamine-, and Cy5.5-conjugated phosphine reagents. Among these reagents, the Cy5.5 derivative afforded the best sensitivity because of its intrinsically low nonspecific cell binding activity and concomitantly low background fluorescence.

The background fluorescence that is frequently associated with poor clearance of unreacted fluorophore can be minimized by using “smart” probes, which become fluorescent only after reaction with their target. Lemieux et al. (84) developed a smart phosphine probe based on a coumarin scaffold (Fig. 4A). Before reaction, the phosphine is in the reduced state and its lone pair of electrons quenches the coumarin's fluorescence; however, after Staudinger ligation with azides, the resulting phosphine oxide eliminates quenching to yield a fluorescent product. The reagent was still prone to some background fluorescence because the phosphine oxide is generated both by nonspecific oxidation and the Staudinger ligation. More recently, Hangauer et al. (85) described the use of a red-shifted fluorogenic phosphine reagent that overcomes the limitations of its predecessor and shows promise for in vivo imaging applications (Fig. 4B). Capitalizing on the Staudinger ligation's mechanism (86), we introduced a fluorescence quencher at the ester group that is cleaved during the course of the reaction. Consequently, background fluorescence derived from the unreacted probe was minimized and labeled glycans could be visualized on cells with high sensitivity.

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

Fluorogenic phosphine dyes activated by Staudinger ligation with azides. (A) Fluorogenic phosphine in which the phosphine lone-pair electrons quench the fluorescence of the coumarin fluorophore. Staudinger ligation or nonspecific oxidation sequesters the lone-pair electrons and generates a fluorescent product. (B) A fluorogenic phosphine that utilizes a FRET quencher, which is cleaved during the Staudinger reaction but not during nonspecific oxidation.

Wong and coworkers (68, 82) developed a smart probe to visualize 6AzFuc-, alkynyl fucose-, and alkynyl ManNAc-labeled glycans on fixed cells by using the CuAAC reaction (Fig. 5A). This fluorogenic reagent comprised a 1,8-napthalimide scaffold with a pendant azide or alkyne group positioned to quench the molecule's fluorescence. Reaction of the dye's azide or alkyne moiety with a complementary azido or alkynyl sugar resulted in a significant fluorescence enhancement. When using the azide-containing 1,8-napthalimide probe for fixed cell imaging, however, the authors observed high background fluorescence (68) and turned to a similar azide-bearing smart probe based on a coumarin scaffold (Fig. 5B) (87). Interestingly, after fixation and permeabilization of azide-labeled cells, these quenched fluorophores enabled the visualization of fucose residues inside the cell, likely those trafficking through the secretory pathway.

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

Fluorescent dyes activated by the CuAAC reaction based on (A) 1,8-napthalimide or (B) coumarin scaffolds. After the reaction, the triazole modifies the electronics of the fluorophore to yield a fluorescent product.

Imaging Glycans in Living Organisms.

Ultimately, the constituents of the glycome must be visualized in living organisms to capture glycans in action as they perform their myriad functions. In principle, the Staudinger ligation and strain-promoted reaction of azides and cyclooctynes are applicable to in vivo imaging because the reagents involved are both bioorthogonal and devoid of intrinsic toxicity. Indeed, the Staudinger ligation has been shown to proceed in live mice, enabling the covalent tagging of SiaNAz- or GalNAz-modified glycoproteins in various tissues (72, 76). However, the Staudinger ligation suffers from sluggish reaction kinetics so that fast (i.e., less than a few hours long) biological processes involving glycans cannot be studied in real time.

By contrast, the reaction of azides with cyclooctynes (Cu-free click chemistry) has the potential for much improved kinetics under physiological conditions. Baskin et al. (64) demonstrated that a cyclooctyne reagent bearing a gem-difluoro group adjacent to the alkyne, termed “DIFO” (Fig. 6A), reacts 30–60 times faster with azides than nonfluorinated cyclooctynes or Staudinger ligation reagents. The superior reactivity of DIFO coupled with its selectivity and biocompatibility enabled the analysis of glycan trafficking dynamics in live cells (64). Azide-labeled glycans were reacted with a DIFO–fluorophore conjugate for 1 minute and the movement of the glycans within the cell was tracked by fluorescence microscopy. Further, pulse–chase experiments were performed in which azido glycans produced at different time points were labeled with discrete fluorophores. Thus, temporally distinct glycan populations could be color-coded as “old” or “new.” The addition of fused phenyl rings to the cyclooctyne scaffold can also increase its reactivity with azides, a phenomenon exploited by Boons and coworkers in generating alternative reagents for visualizing cell-surface azido glycans (88).

Fig. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6.

Application of the bioorthogonal chemical reporter strategy for in vivo imaging of glycans. (A) Zebrafish embryos were treated with azidosugars during their development, resulting in metabolic labeling of glycans with azides. The azides were visualized by reaction with fluorescent DIFO reagents. (B) An example of a zebrafish embryo metabolically labeled with Ac4GalNAz and reacted with Alexa Fluor 647-conjugated DIFO (DIFO-647) at 60 h postfertilization (hpf) followed by Alexa Fluor 488-conjugated DIFO (DIFO-488) at 63 hpf to detect newly synthesized glycans. (Left) Single z-plane brightfield image. (Left Center) z-projection of DIFO-647 fluorescence. (Right Center) z-projection of DIFO-488 fluorescence. (Right) z-projection of DIFO-647 and DIFO-488 fluorescence merge. (Scale bar, 100 μm.)

The strain-promoted cycloaddition of azides with DIFO reagents has recently been extended to visualization of glycans in developing zebrafish, the first example of glycan imaging in a living organism (Fig. 6A) (73). The zebrafish is well suited to optical imaging because it develops ex utero and is transparent during most of the process (89). Further, zebrafish embryogenesis, a popular model for vertebrate development, is well characterized morphologically (90). Zebrafish embryos were grown in media containing GalNAz or ManNAz, resulting in metabolic labeling of mucin-type O-linked glycans or sialylated glycans, respectively, with azides. Glycans produced at various time-points during development were imaged by simply bathing the embryos with DIFO–fluorophore conjugates. Multicolor labeling experiments allowed the discrimination of temporally distinct glycan populations and analysis of their trafficking patterns during development (Fig. 6B).

Future Prospects

Glycans have now been added to the list of biological targets amenable to in vivo interrogation with molecular imaging techniques. The bioorthogonal chemical reporter approach has been successfully implemented to image glycans in developing zebrafish, thus augmenting the arsenal of tools for probing the dynamic glycome. Similar applications in other model organisms such as Drosophila and C. elegans are on the horizon, and further extension to mammalian disease models and even human clinical settings are worthy of pursuit. These future goals will be accompanied by new challenges, such as designing reagents based on consideration of metabolic stability and pharmacokinetic properties in addition to selectivity and kinetics.

In addition, new chemistries will be required to expand the fraction of the glycome that is revealed by using chemical reporters. A single azidosugar labels only a portion of the glycome; multiple unnatural sugars will be required to achieve broader coverage. Distinguishing multiple sugars will require additional chemical reporters that can be visualized independently of azides and alkynes. Thus, a major challenge in the field involves identifying small, bioorthogonal functional groups that are also orthogonal to the reagents described above. A collection of such reagents would enable a more thorough analysis of how glycan patterns change during normal and pathological processes.

Acknowledgments

We thank J. Baskin and K. Dehnert for helpful discussions. This work was supported by National Institutes of Health Grant GM58867 (to C.R.B.).

Footnotes

  • 1To whom correspondence should be addressed. E-mail: crb{at}berkeley.edu
  • This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2005.

  • Author contributions: S.T.L. and C.R.B. wrote the paper.

  • The authors declare no conflict of interest.

  • © 2008 by The National Academy of Sciences of the USA

References

  1. ↵
    1. Weissleder R,
    2. Ntziachristos V
    (2003) Shedding light onto live molecular targets. Nat Med 9:123–128.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Giepmans BN,
    2. Adams SR,
    3. Ellisman MH,
    4. Tsien RY
    (2006) The fluorescent toolbox for assessing protein location and function. Science 312:217–224.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Lecuyer E,
    2. et al.
    (2007) Global analysis of mRNA localization reveals a prominent role in organizing cellular architecture and function. Cell 131:174–187.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Du W,
    2. Wang Y,
    3. Luo Q,
    4. Liu BF
    (2006) Optical molecular imaging for systems biology: From molecule to organism. Anal Bioanal Chem 386:444–457.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Villalobos V,
    2. Naik S,
    3. Piwnica-Worms D
    (2007) Current state of imaging protein-protein interactions in vivo with genetically encoded reporters. Annu Rev Biomed Eng 9:321–349.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Demaurex N
    (2005) Calcium measurements in organelles with Ca2+-sensitive fluorescent proteins. Cell calcium 38:213–222.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Dobbie IM,
    2. Lowndes NF,
    3. Sullivan KF
    (2008) Autofluorescent proteins. Methods Cell Biol 85:1–22.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Miyawaki A,
    2. et al.
    (1997) Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. Nature 388:882–887.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Zeng L,
    2. Miller EW,
    3. Pralle A,
    4. Isacoff EY,
    5. Chang CJ
    (2006) A selective turn-on fluorescent sensor for imaging copper in living cells. J Am Chem Soc 128:10–11.
    OpenUrlCrossRefPubMed
  10. ↵
    1. He Q,
    2. Miller EW,
    3. Wong AP,
    4. Chang CJ
    (2006) A selective fluorescent sensor for detecting lead in living cells. J Am Chem Soc 128:9316–9317.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Chang CJ,
    2. Jaworski J,
    3. Nolan EM,
    4. Sheng M,
    5. Lippard SJ
    (2004) A tautomeric zinc sensor for ratiometric fluorescence imaging: Application to nitric oxide-induced release of intracellular zinc. Proc Natl Acad Sci USA 101:1129–1134.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Yoon S,
    2. Miller EW,
    3. He Q,
    4. Do PH,
    5. Chang CJ
    (2007) A bright and specific fluorescent sensor for mercury in water, cells, and tissue. Angew Chem Int Ed 46:6658–6661.
    OpenUrlCrossRef
  13. ↵
    1. Dunn TA,
    2. Feller MB
    (2008) Imaging second messenger dynamics in developing neural circuits. Dev Neurobiol 68:835–844.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Miller EW,
    2. Tulyathan O,
    3. Isacoff EY,
    4. Chang CJ
    (2007) Molecular imaging of hydrogen peroxide produced for cell signaling. Nat Chem Biol 3:263–267.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Prescher JA,
    2. Bertozzi CR
    (2005) Chemistry in living systems. Nat Chem Biol 1:13–21.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Ohtsubo K,
    2. Marth JD
    (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126:855–867.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Bishop JR,
    2. Schuksz M,
    3. Esko JD
    (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446:1030–1037.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Haltiwanger RS,
    2. Lowe JB
    (2004) Role of Glycosylation in Development. Annu Rev Biochem 73:491–537.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Rosen SD
    (2004) Ligands for L-selectin: Homing, inflammation, and beyond. Annu Rev Immunol 22:129–156.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Fuster MM,
    2. Esko JD
    (2005) The sweet and sour of cancer: Glycans as novel therapeutic targets. Nat Rev Cancer 5:526–542.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Dennis JW,
    2. Granovsky M,
    3. Warren CE
    (1999) Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1473:21–34.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Hricovini M
    (2004) Structural aspects of carbohydrates and the relation with their biological properties. Curr Med Chem 11:2565–2583.
    OpenUrlPubMed
  23. ↵
    1. Freeze HH
    (2006) Genetic defects in the human glycome. Nat Rev Genet 7:537–551.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Prescher JA,
    2. Bertozzi CR
    (2006) Chemical technologies for probing glycans. Cell 126:851–854.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Sharon N
    (2007) Lectins: Carbohydrate-specific reagents and biological recognition molecules. J Biol Chem 282:2753–2764.
    OpenUrlFREE Full Text
  26. ↵
    1. Pilobello KT,
    2. Mahal LK
    (2007) Lectin microarrays for glycoprotein analysis. Methods Mol Biol 385:193–203.
    OpenUrlPubMed
  27. ↵
    1. Hirabayashi J
    (2004) Lectin-based structural glycomics: Glycoproteomics and glycan profiling. Glycoconj J 21:35–40.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Lehmann F,
    2. Tiralongo E,
    3. Tiralongo J
    (2006) Sialic acid-specific lectins: Occurrence, specificity and function. Cell Mol Life Sci 63:1331–1354.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Pereira ME,
    2. Kisailus EC,
    3. Gruezo F,
    4. Kabat EA
    (1978) Immunochemical studies on the combining site of the blood group H-specific lectin 1 from Ulex europeus seeds. Arch Biochem Biophys 185:108–115.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Ishiyama I,
    2. Uhlenbruck G
    (1971) On the nature of the anti-dextran activity of the Helix pomatia “anti A” agglutinin. Z Naturforsch B 266:1198–1199.
    OpenUrlPubMed
  31. ↵
    1. Mrkoci K,
    2. Kelm S,
    3. Crocker PR,
    4. Schauer R,
    5. Berger EG
    (1996) Constitutively hyposialylated human T-lymphocyte clones in the Tn-syndrome: Binding characteristics of plant and animal lectins. Glycoconj J 13:567–573.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Fan JQ,
    2. Lee YC
    (1997) Detailed studies on substrate structure requirements of glycoamidases A and F. J Biol Chem 272:27058–27064.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Kiessling LL,
    2. Pohl NL
    (1996) Strength in numbers: Non-natural polyvalent carbohydrate derivatives. Chem Biol 3:71–77.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Ohba H,
    2. Bakalova R
    (2003) Relationships between degree of binding, cytotoxicity and cytoagglutinating activity of plant-derived agglutinins in normal lymphocytes and cultured leukemic cell lines. Cancer Chemother Pharmacol 51:451–458.
    OpenUrlPubMed
  35. ↵
    1. Schwarz RE,
    2. Wojciechowicz DC,
    3. Picon AI,
    4. Schwarz MA,
    5. Paty PB
    (1999) Wheatgerm agglutinin-mediated toxicity in pancreatic cancer cells. Br J Cancer 80:1754–1762.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Carlsson S,
    2. Carlsson MC,
    3. Leffler H
    (2007) Intracellular sorting of galectin-8 based on carbohydrate fine specificity. Glycobiology 17:906–912.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Lizzi AR,
    2. et al.
    (2007) Pattern expression of glycan residues in AZT-treated K562 cells analyzed by lectin cytochemistry. Mol Cell Biochem 300:29–37.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Griffith CM,
    2. Wiley MJ
    (1989) The distribution of cell surface glycoconjugates during mouse secondary neurulation. Anat Embryol 180:567–575.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Griffith CM,
    2. Sanders EJ
    (1991) Changes in glycoconjugate expression during early chick embryo development: A lectin-binding study. Anat Rec 231:238–250.
    OpenUrlCrossRefPubMed
  40. ↵
    1. Tian E,
    2. Hagen KG
    (2007) O-linked glycan expression during Drosophila development. Glycobiology 17:820–827.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. Paessens LC,
    2. Garcia-Vallejo JJ,
    3. Fernandes RJ,
    4. van Kooyk Y
    (2007) The glycosylation of thymic microenvironments. A microscopic study using plant lectins. Immunol Lett 110:65–73.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Thurston G,
    2. Baluk P,
    3. Hirata A,
    4. McDonald DM
    (1996) Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am J Physiol 271:H2547–2562.
    OpenUrlPubMed
  43. ↵
    1. Truong LD,
    2. Phung VT,
    3. Yoshikawa Y,
    4. Mattioli CA
    (1988) Glycoconjugates in normal human kidney. A histochemical study using 13 biotinylated lectins. Histochemistry 90:51–60.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Link CD,
    2. Ehrenfels CW,
    3. Wood WB
    (1988) Mutant expression of male copulatory bursa surface markers in Caenorhabditis elegans. Development (Cambridge, U.K.) 103:485–495.
    OpenUrlAbstract
  45. ↵
    1. Link CD,
    2. Silverman MA,
    3. Breen M,
    4. Watt KE,
    5. Dames SA
    (1992) Characterization of Caenorhabditis elegans lectin-binding mutants. Genetics 131:867–881.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. David G,
    2. Bai XM,
    3. Van der Schueren B,
    4. Cassiman JJ,
    5. Van den Berghe H
    (1992) Developmental changes in heparan sulfate expression: In situ detection with mAbs. J Cell Biol 119:961–975.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Avnur Z,
    2. Geiger B
    (1984) Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using specific monoclonal antibody. Cell 38:811–822.
    OpenUrlCrossRefPubMed
  48. ↵
    1. Duijvestijn AM,
    2. et al.
    (1988) High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am J Pathol 130:147–155.
    OpenUrlPubMed
  49. ↵
    1. Streeter PR,
    2. Rouse BT,
    3. Butcher EC
    (1988) Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 107:1853–1862.
    OpenUrlAbstract/FREE Full Text
  50. ↵
    1. Comer FI,
    2. Vosseller K,
    3. Wells L,
    4. Accavitti MA,
    5. Hart GW
    (2001) Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal Biochem 293:169–177.
    OpenUrlCrossRefPubMed
  51. ↵
    1. Hang HC,
    2. Bertozzi CR
    (2001) Chemoselective approaches to glycoprotein assembly. Acc Chem Res 34:727–736.
    OpenUrlCrossRefPubMed
  52. ↵
    1. de Graffenried CL,
    2. Laughlin ST,
    3. Kohler JJ,
    4. Bertozzi CR
    (2004) A small-molecule switch for Golgi sulfotransferases. Proc Natl Acad Sci USA 101:16715–16720.
    OpenUrlAbstract/FREE Full Text
  53. ↵
    1. Young RD,
    2. et al.
    (2007) Keratan sulfate glycosaminoglycan and the association with collagen fibrils in rudimentary lamellae in the developing avian cornea. Invest Ophthalmol Vis Sci 48:3083–3088.
    OpenUrlAbstract/FREE Full Text
  54. ↵
    1. Hodgkinson AJ,
    2. Carpenter EA,
    3. Smith CS,
    4. Molan PC,
    5. Prosser CG
    (2007) Adhesion molecule expression in the bovine mammary gland. Vet Immunol Immunopathol 115:205–215.
    OpenUrlCrossRefPubMed
  55. ↵
    1. Sinha RK,
    2. Yang G,
    3. Alexander C,
    4. Mage RG
    (2006) De novo expression of MECA-79 glycoprotein-determinant on developing B lymphocytes in gut-associated lymphoid tissues. Immunology 119:461–469.
    OpenUrlCrossRefPubMed
  56. ↵
    1. Reza JN,
    2. Ritter MA
    (1994) Differential expression of adhesion molecules within the human thymus. Dev Immunol 4:55–64.
    OpenUrlCrossRefPubMed
  57. ↵
    1. Licha K,
    2. et al.
    (2005) Optical molecular imaging of lymph nodes using a targeted vascular contrast agent. J Biomed Opt 10:41205.
    OpenUrlCrossRefPubMed
  58. ↵
    1. Hemmerich S,
    2. Rosen SD
    (2000) Carbohydrate sulfotransferases in lymphocyte homing. Glycobiology 10:849–856.
    OpenUrlAbstract/FREE Full Text
  59. ↵
    1. Mahal LK,
    2. Yarema KJ,
    3. Bertozzi CR
    (1997) Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis. Science 276:1125–1128.
    OpenUrlAbstract/FREE Full Text
  60. ↵
    1. Saxon E,
    2. Bertozzi CR
    (2000) Cell surface engineering by a modified Staudinger reaction. Science 287:2007–2010.
    OpenUrlAbstract/FREE Full Text
  61. ↵
    1. Rostovtsev VV,
    2. Green LG,
    3. Fokin VV,
    4. Sharpless KB
    (2002) A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes. Angew Chem Int Ed 41:2596–2599.
    OpenUrlCrossRef
  62. ↵
    1. Tornoe CW,
    2. Christensen C,
    3. Meldal M
    (2002) Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J Org Chem 67:3057–3064.
    OpenUrlCrossRefPubMed
  63. ↵
    1. Agard NJ,
    2. Prescher JA,
    3. Bertozzi CR
    (2004) A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems. J Am Chem Soc 126:15046–15047.
    OpenUrlCrossRefPubMed
  64. ↵
    1. Baskin JM,
    2. et al.
    (2007) Copper-free click chemistry for dynamic in vivo imaging. Proc Natl Acad Sci USA 104:16793–16797.
    OpenUrlAbstract/FREE Full Text
  65. ↵
    1. Agard NJ,
    2. Baskin JM,
    3. Prescher JA,
    4. Lo A,
    5. Bertozzi CR
    (2006) A comparative study of bioorthogonal reactions with azides. ACS Chem Biol 1:644–648.
    OpenUrlCrossRefPubMed
  66. ↵
    1. Schauer R
    (2000) Achievements and challenges of sialic acid research. Glycoconj J 17:485–499.
    OpenUrlCrossRefPubMed
  67. ↵
    1. Varki NM,
    2. Varki A
    (2007) Diversity in cell surface sialic acid presentations: Implications for biology and disease. Lab Invest 87:851–857.
    OpenUrlCrossRefPubMed
  68. ↵
    1. Hsu TL,
    2. et al.
    (2007) Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells. Proc Natl Acad Sci USA 104:2614–2619.
    OpenUrlAbstract/FREE Full Text
  69. ↵
    1. Luchansky SJ,
    2. Goon S,
    3. Bertozzi CR
    (2004) Expanding the diversity of unnatural cell-surface sialic acids. ChemBioChem 5:371–374.
    OpenUrlCrossRefPubMed
  70. ↵
    1. Kosa RE,
    2. Brossmer R,
    3. Gross HJ
    (1993) Modification of cell surfaces by enzymatic introduction of special sialic acid analogues. Biochem Biophys Res Commun 190:914–920.
    OpenUrlCrossRefPubMed
  71. ↵
    1. Luchansky SJ,
    2. Argade S,
    3. Hayes BK,
    4. Bertozzi CR
    (2004) Metabolic functionalization of recombinant glycoproteins. Biochemistry 43:12358–12366.
    OpenUrlCrossRefPubMed
  72. ↵
    1. Prescher JA,
    2. Dube DH,
    3. Bertozzi CR
    (2004) Chemical remodelling of cell surfaces in living animals. Nature 430:873–877.
    OpenUrlCrossRefPubMed
  73. ↵
    1. Laughlin ST,
    2. Baskin JM,
    3. Amacher SL,
    4. Bertozzi CR
    (2008) In vivo imaging of membrane-associated glycans in developing zebrafish. Science 320:664–667.
    OpenUrlAbstract/FREE Full Text
  74. ↵
    1. Hanson SR,
    2. et al.
    (2007) Tailored glycoproteomics and glycan site mapping using saccharide-selective bioorthogonal probes. J Am Chem Soc 129:7266–7267.
    OpenUrlCrossRefPubMed
  75. ↵
    1. Hang HC,
    2. Yu C,
    3. Kato DL,
    4. Bertozzi CR
    (2003) A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation. Proc Natl Acad Sci USA 100:14846–14851.
    OpenUrlAbstract/FREE Full Text
  76. ↵
    1. Dube DH,
    2. Prescher JA,
    3. Quang CN,
    4. Bertozzi CR
    (2006) Probing mucin-type O-linked glycosylation in living animals. Proc Natl Acad Sci USA 103:4819–4824.
    OpenUrlAbstract/FREE Full Text
  77. ↵
    1. Hart GW,
    2. Housley MP,
    3. Slawson C
    (2007) Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446:1017–1022.
    OpenUrlCrossRefPubMed
  78. ↵
    1. Vocadlo DJ,
    2. Hang HC,
    3. Kim EJ,
    4. Hanover JA,
    5. Bertozzi CR
    (2003) A chemical approach for identifying O-GlcNAc-modified proteins in cells. Proc Natl Acad Sci USA 100:9116–9121.
    OpenUrlAbstract/FREE Full Text
  79. ↵
    1. Laughlin ST,
    2. Bertozzi CR
    (2007) Metabolic labeling of glycans with azido sugars and subsequent glycan-profiling and visualization via Staudinger ligation. Nat Protoc 2:2930–2944.
    OpenUrlCrossRefPubMed
  80. ↵
    1. Becker DJ,
    2. Lowe JB
    (2003) Fucose: Biosynthesis and biological function in mammals. Glycobiology 13:41R–53R.
    OpenUrlAbstract/FREE Full Text
  81. ↵
    1. Rabuka D,
    2. Hubbard SC,
    3. Laughlin ST,
    4. Argade SP,
    5. Bertozzi CR
    (2006) A chemical reporter strategy to probe glycoprotein fucosylation. J Am Chem Soc 128:12078–12079.
    OpenUrlCrossRefPubMed
  82. ↵
    1. Sawa M,
    2. et al.
    (2006) Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo. Proc Natl Acad Sci USA 103:12371–12376.
    OpenUrlAbstract/FREE Full Text
  83. ↵
    1. Chang PV,
    2. Prescher JA,
    3. Hangauer MJ,
    4. Bertozzi CR
    (2007) Imaging cell surface glycans with bioorthogonal chemical reporters. J Am Chem Soc 129:8400–8401.
    OpenUrlCrossRefPubMed
  84. ↵
    1. Lemieux GA,
    2. De Graffenried CL,
    3. Bertozzi CR
    (2003) A fluorogenic dye activated by the staudinger ligation. J Am Chem Soc 125:4708–4709.
    OpenUrlCrossRefPubMed
  85. ↵
    1. Hangauer MJ,
    2. Bertozzi CR
    (2008) A FRET-based fluorogenic phosphine for live-cell imaging with the Staudinger ligation. Angew Chem Int Ed 47:2394–2397.
    OpenUrlCrossRef
  86. ↵
    1. Lin FL,
    2. Hoyt HM,
    3. van Halbeek H,
    4. Bergman RG,
    5. Bertozzi CR
    (2005) Mechanistic investigation of the staudinger ligation. J Am Chem Soc 127:2686–2695.
    OpenUrlCrossRefPubMed
  87. ↵
    1. Sivakumar K,
    2. et al.
    (2004) A fluorogenic 1,3-dipolar cycloaddition reaction of 3-azidocoumarins and acetylenes. Org Lett 6:4603–4606.
    OpenUrlCrossRefPubMed
  88. ↵
    1. Ning X,
    2. Guo J,
    3. Wolfert MA,
    4. Boons GJ
    (2008) Visualizing metabolically labeled glycoconjugates of living cells by copper-free and fast huisgen cycloadditions. Angew Chem Int Ed 47:2253–2255.
    OpenUrlCrossRef
  89. ↵
    1. Westerfield M
    (2000) The Zebrafish Book: A guide for the Laboratory Use of Zebrafish (Danio rerio) (Univ of Oregon Press, Eugene, OR).
  90. ↵
    1. Kimmel CB,
    2. Ballard WW,
    3. Kimmel SR,
    4. Ullmann B,
    5. Schilling TF
    (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203:253–310.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Imaging the glycome
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Imaging the glycome
Scott T. Laughlin, Carolyn R. Bertozzi
Proceedings of the National Academy of Sciences Jan 2009, 106 (1) 12-17; DOI: 10.1073/pnas.0811481106

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Imaging the glycome
Scott T. Laughlin, Carolyn R. Bertozzi
Proceedings of the National Academy of Sciences Jan 2009, 106 (1) 12-17; DOI: 10.1073/pnas.0811481106
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley

Article Classifications

  • Physical Sciences
  • Chemistry
  • Biological Sciences
  • Cell Biology

Related Articles

  • Profile of Carolyn Bertozzi
    - Feb 16, 2010
Proceedings of the National Academy of Sciences: 106 (1)
Table of Contents

Submit

Sign up for Article Alerts

Jump to section

  • Article
    • Abstract
    • Imaging Glycans with Lectins and Antibodies
    • Imaging Glycans with Bioorthogonal Chemical Reporters
    • Future Prospects
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Water from a faucet fills a glass.
News Feature: How “forever chemicals” might impair the immune system
Researchers are exploring whether these ubiquitous fluorinated molecules might worsen infections or hamper vaccine effectiveness.
Image credit: Shutterstock/Dmitry Naumov.
Reflection of clouds in the still waters of Mono Lake in California.
Inner Workings: Making headway with the mysteries of life’s origins
Recent experiments and simulations are starting to answer some fundamental questions about how life came to be.
Image credit: Shutterstock/Radoslaw Lecyk.
Cave in coastal Kenya with tree growing in the middle.
Journal Club: Small, sharp blades mark shift from Middle to Later Stone Age in coastal Kenya
Archaeologists have long tried to define the transition between the two time periods.
Image credit: Ceri Shipton.
Illustration of groups of people chatting
Exploring the length of human conversations
Adam Mastroianni and Daniel Gilbert explore why conversations almost never end when people want them to.
Listen
Past PodcastsSubscribe
Panda bear hanging in a tree
How horse manure helps giant pandas tolerate cold
A study finds that giant pandas roll in horse manure to increase their cold tolerance.
Image credit: Fuwen Wei.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Subscribers
  • Librarians
  • Press
  • Cozzarelli Prize
  • Site Map
  • PNAS Updates
  • FAQs
  • Accessibility Statement
  • Rights & Permissions
  • About
  • Contact

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490